Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3946

Scholar Rock reports competitive data for muscle-preserving obesity drug add-on

$
0
0
Scholar Rock’s muscle-building antibody helped patients who are overweight or obese preserve lean mass when they were taking Eli Lilly’s incretin drug Zepbound, the biotech said Wednesday. In a Phase 2 study called EMBRAZE, patients ...

Viewing all articles
Browse latest Browse all 3946

Latest Images

Trending Articles



Latest Images